PubRank
Search
About
F Piscaglia
Author PubWeight™ 65.26
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Ultraschall Med
2012
4.21
2
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Gut
2001
4.12
3
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.
Ultraschall Med
2008
3.49
4
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications.
Ultraschall Med
2013
2.93
5
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology.
Ultraschall Med
2013
2.73
6
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.
Gastroenterology
1999
2.30
7
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
Cancer Treat Rev
2010
2.09
8
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.
Am J Transplant
2008
2.06
9
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy.
J Hepatol
1997
1.98
10
Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.
Dig Liver Dis
2008
1.65
11
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.
Gut
2004
1.44
12
Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair.
Histochem Cell Biol
1999
1.43
13
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.
Ultraschall Med
2012
1.29
14
Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma.
Hepatology
2001
1.12
15
Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension.
Ultraschall Med
2012
1.07
16
New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice.
Dig Liver Dis
2007
1.04
17
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.
Dig Dis Sci
1997
1.03
18
High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
Gut
2006
1.00
19
Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand".
J Hepatol
2012
0.97
20
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
Aliment Pharmacol Ther
2012
0.91
21
Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography.
Dig Liver Dis
2004
0.91
22
Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities.
Am J Gastroenterol
2000
0.90
23
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.
Gut
2006
0.89
24
Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis.
Clin Exp Immunol
1999
0.89
25
Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics.
Am J Gastroenterol
2001
0.87
26
Ultrasound in portal hypertension--part 1.
Ultraschall Med
2011
0.86
27
Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients.
Int J Artif Organs
2006
0.84
28
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Clin Cancer Res
1999
0.84
29
Sonographic assessment of the distal end of the thoracic duct in healthy volunteers and in patients with portal hypertension.
AJR Am J Roentgenol
1995
0.84
30
Vascularity of liver tumours and recent advances in doppler ultrasound.
J Hepatol
2001
0.83
31
Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT.
Radiol Med
2009
0.83
32
Liver cirrhosis, ascites, and hyperfibrinolysis.
Am J Gastroenterol
2001
0.82
33
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis.
Aliment Pharmacol Ther
2007
0.82
34
Hemodynamics in focal nodular hyperplasia.
J Hepatol
1999
0.82
35
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.
Aliment Pharmacol Ther
2008
0.81
36
[Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
Radiol Med
1998
0.81
37
Circadian occurrence of variceal bleeding in patients with liver cirrhosis.
J Gastroenterol Hepatol
1996
0.80
38
Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax.
Ultraschall Med
2008
0.78
39
Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation.
Endoscopy
2011
0.77
40
Review article: liver transplantation for HCC. Treatment options on the waiting list.
Aliment Pharmacol Ther
2003
0.77
41
Mars and Prometheus: our clinical experience in acute chronic liver failure.
Transplant Proc
2008
0.76
42
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria (Br J Surg 2011; 98: 1201-1208).
Br J Surg
2011
0.76
43
Review article: percutaneous treatment of hepatocellular carcinoma.
Aliment Pharmacol Ther
2003
0.76
44
Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study.
Liver
1996
0.76
45
Management of small hepatocellular carcinoma.
Acta Gastroenterol Belg
2006
0.76
46
Intrahepatic artery pseudoaneurysm: a possible complication of blind thoracentesis.
J Clin Ultrasound
1999
0.76
47
Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis.
Ultraschall Med
2007
0.76
48
Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study.
Ital J Gastroenterol Hepatol
1997
0.76
49
Cigarette smoking, abdominal blood flow and abdominal diseases.
J Gastroenterol Hepatol
1996
0.75
50
Left ventricular function in liver cirrhosis.
J Hepatol
1996
0.75
51
Prophylaxis of post-ERCP pancreatic complications with gabexate.
Dig Liver Dis
2007
0.75
52
Splanchnic arterial Doppler parameters in portal hypertension.
Hepatology
1999
0.75
53
Diagnosis and management of hepatic focal nodular hyperplasia.
J Ultrasound
2007
0.75
54
Diagnosis of cirrhosis and portal hypertension.
Am J Gastroenterol
1998
0.75
55
Hepatic artery resistance in portal vein thrombosis.
Radiology
1996
0.75
56
Possible mechanisms for changes of intrasplenic arterial impedance indices in portal hypertension.
Hepatology
1997
0.75
57
Cardiac abnormalities in cirrhosis.
Am J Gastroenterol
2001
0.75
58
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Ultraschall Med
2013
0.75
59
The chronically ill elderly patients discharged from the hospital: interim report from a controlled study of home care attendance.
Arch Gerontol Geriatr Suppl
2004
0.75
60
Nodule in nodule: malignant transformation of a macroregenerative nodule in cirrhosis revealed by duplex-Doppler.
J Hepatol
1999
0.75
61
Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.
Dig Dis Sci
2000
0.75
62
[Ultrasound: the only "one stop shop" for modern management of liver disease].
Ultraschall Med
2013
0.75